Vandetanib, sold under the brand name Caprelsa, is an anti-cancer medication that is used for the treatment of certain tumours of the thyroid gland. It...
14 KB (1,191 words) - 04:16, 26 September 2024
Österreichischer Apothekerverlag. Sedacoron 200 mg-Tabletten. "Caprelsa (vandetanib) Tablets, for Oral Use. Full Prescribing Information" (PDF). Sanofi Genzyme...
23 KB (2,515 words) - 08:39, 9 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
10 KB (579 words) - 06:46, 26 June 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
27 KB (3,078 words) - 19:34, 17 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
34 KB (3,021 words) - 12:39, 5 August 2024
abnormalities, and thrombotic or bleeding episodes.[citation needed] Vandetanib, trade name Caprelsa, was the first drug (April 2011) to be approved by...
19 KB (2,285 words) - 11:17, 14 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
13 KB (1,177 words) - 02:19, 4 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
20 KB (1,566 words) - 08:58, 12 August 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
69 KB (6,048 words) - 05:15, 1 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
64 KB (7,430 words) - 15:53, 14 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
121 KB (13,799 words) - 17:37, 8 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
5 KB (412 words) - 23:17, 19 June 2023
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
25 KB (2,086 words) - 02:24, 16 July 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
25 KB (3,124 words) - 21:38, 18 August 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
68 KB (5,999 words) - 20:41, 31 August 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
105 KB (12,338 words) - 00:34, 29 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
40 KB (4,578 words) - 12:30, 10 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
24 KB (2,877 words) - 15:03, 1 October 2024
Nintedanib Odronextamab Pazopanib Pemigatinib Pexidartinib Quizartinib Regorafenib Ripretinib Sorafenib Sunitinib Tebentafusp Tepotinib Vandetanib Venetoclax...
12 KB (821 words) - 02:57, 12 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
26 KB (2,420 words) - 02:40, 26 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
43 KB (5,251 words) - 10:44, 24 June 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
7 KB (492 words) - 08:38, 3 October 2024
cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired...
31 KB (2,632 words) - 12:59, 20 October 2024
cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired...
56 KB (5,566 words) - 04:53, 25 September 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
10 KB (661 words) - 04:10, 26 June 2024
cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired...
42 KB (3,486 words) - 00:32, 30 September 2024
cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran Zafirlukast Zolmitriptan Predecessors and acquired...
42 KB (3,798 words) - 08:17, 19 October 2024
lenvatinib cancer pazopanib cancer ponatinib cancer ramucirumab cancer ranibizumab AMD regorafenib cancer sorafenib cancer sunitinib cancer vandetanib cancer...
14 KB (1,693 words) - 18:18, 18 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
15 KB (976 words) - 17:10, 20 October 2024
inhibitors: Vandetanib GFRα2 Agonists: Neurturin (NRTN) Kinase inhibitors: Vandetanib GFRα3 Agonists: Artemin (ARTN) Kinase inhibitors: Vandetanib GFRα4 Agonists:...
10 KB (1,131 words) - 19:14, 31 March 2024